Early Research Signals Potential for CAR T-Cell Therapy in EGFRvIII-Positive GBM
A pilot study of the efficacy of CAR T-cell therapy in patients with EGFRvIII-positive glioblastoma multiforme (GBM) has generated encouraging findings.
